Amneal Pharmaceuticals, Inc.

Amneal Pharmaceuticals, Inc. is a global biopharmaceutical company that develops, manufactures, markets, and distributes a wide range of pharmaceutical products. Its operations are divided into three segments: Affordable Medicines, Specialty, and AvKARE. The Affordable Medicines segment offers various dosage forms including immediate and extended-release oral solids, powders, liquids, sterile injectables, nasal sprays, inhalation and respiratory products, biosimilars, ophthalmics, films, transdermal patches, and topicals. The Specialty segment focuses on central nervous system and endocrine disorders, particularly Parkinson's disease, with products like Rytary (carbidopa-levodopa), CREXONT, and also Unithroid and ONGENTYS for hypothyroidism. The AvKARE segment supplies pharmaceuticals, medical and surgical products, and services to governmental agencies, the Department of Defense, and the Department of Veterans Affairs, and distributes bottle and unit dose pharmaceuticals under the AvKARE and AvPAK names.

Amneal Pharmaceuticals, Inc. is listed on the Nasdaq Global Select Market (NasdaqGS) under the ticker symbol AMRX. The company trades in United States Dollars (USD), as it is headquartered in the United States and its primary listing is on a U.S. exchange. The NasdaqGS is a major stock exchange known for listing many technology and healthcare companies, providing liquidity and visibility for Amneal's shares.

Amneal Pharmaceuticals, Inc. operates in the Healthcare sector and is classified under the Drug Manufacturers - Specialty & Generic industry. This means the company is involved in the research, development, production, and distribution of both generic and specialty branded pharmaceutical products. As a specialty and generic drug manufacturer, Amneal focuses on a broad range of therapeutic areas, including central nervous system disorders, endocrine conditions, and affordable medicines, serving diverse patient needs globally.

Amneal Pharmaceuticals operates through three segments: Affordable Medicines, Specialty, and AvKARE. The Affordable Medicines segment provides a wide array of generic products including oral solids, injectables, nasal sprays, respiratory products, biosimilars, and topicals. The Specialty segment concentrates on central nervous system and endocrine disorders, with key products like Rytary and CREXONT for Parkinson's disease, Unithroid for hypothyroidism, and ONGENTYS. The AvKARE segment supplies pharmaceuticals and medical products to government agencies, the Department of Defense, and the Department of Veterans Affairs, and also distributes unit dose pharmaceuticals under the AvKARE and AvPAK brands. This diverse portfolio allows Amneal to serve both retail and institutional customers.

Amneal Pharmaceuticals sells its products through wholesalers, distributors, retail pharmacies, managed care organizations, and public health entities. The AvKARE segment specifically targets governmental agencies, the Department of Defense, and the Department of Veterans Affairs, providing pharmaceuticals, medical and surgical products, and services. The company's global reach includes markets across the United States and internationally, as it is a global biopharmaceutical company. Its products are distributed to retail and institutional customers, ensuring broad access to both generic and specialty medications for various healthcare settings.